Companion Animal Genetics Market Report: Market Size & Forecast 2026

The global companion animal genetics market focuses on genetic diagnostics and genomic solutions for domesticated pets, with dogs representing the largest animal type segment followed by cats and horses. Valued at approximately $798.3 million in 2024, the market reached roughly $860 million in 2025 and is forecast to continue expanding through 2033-2035 across multiple research projections. The market encompasses genetic disease testing panels, genomic screening services, parentage and pedigree verification, and genomic research tools distributed through private veterinary clinics, direct-to-consumer channels, and public research institutions.

• •Market valued at approximately $798.3 million in 2024, reaching roughly $860 million in 2025
• •Primary animal segments include dogs, cats, horses, and other companion species
• •Product categories include genetic disease testing and genomics-based solutions
• •Distribution spans private veterinary channels and public research institutions

Rising global pet ownership and increased spending on veterinary healthcare are primary catalysts, as pet owners increasingly seek advanced medical and preventive care options for their animals. Concurrently, declining costs of genomic sequencing technologies and bioinformatics tools have made comprehensive genetic testing more accessible to veterinarians and pet owners alike. Growing awareness of hereditary diseases in purebred animals, along with breed-specific health screening requirements, has further accelerated adoption of genetic testing across veterinary practices.

• •Growing pet humanization trend driving increased spending on advanced veterinary diagnostics
• •Declining costs of DNA sequencing and genomic technologies expanding market accessibility
• •Heightened awareness of hereditary conditions in purebred populations fueling demand for disease screening
• •Integration of genetic data into personalized veterinary treatment and breeding programs

The market is segmented by animal type into dogs, cats, horses, and other companion animals, with canine genetics dominating due to the large population of purebred dogs and established breed-specific health registries. By product type, genetic disease testing commands the largest share, while genomics services, including whole-genome sequencing and research applications, represent the fastest-growing segment. Geographically, North America leads the market due to high pet ownership rates, advanced veterinary infrastructure, and strong consumer awareness, while Europe and Asia-Pacific are emerging as significant growth regions driven by expanding middle-class pet spending and improving veterinary technology access.

• •Dogs represent the largest animal segment, followed by cats and horses
• •Genetic disease testing leads the product segment, with genomics services growing rapidly
• •North America holds the largest regional share, supported by high pet spending and veterinary infrastructure
• •Europe and Asia-Pacific are key growth regions driven by rising pet ownership and healthcare access

What are the recent trends and outlook?

The market is positioned for sustained growth through 2030-2035, with projections extending toward $12.59 billion by 2035 under broader market definitions encompassing related genomic services and technologies. Key trends include the integration of artificial intelligence and machine learning for genomic data interpretation, expansion of pharmacogenomic applications for personalized veterinary medicine, and increasing collaboration between genetic testing companies and veterinary research institutions. As regulatory frameworks evolve and consumer awareness grows, the market is expected to see consolidation among larger animal health corporations acquiring specialized genetic testing platforms.

• •AI and machine learning tools are enhancing genomic data analysis and breed-predisposition risk modeling
• •Pharmacogenomics and personalized medicine applications are emerging in veterinary treatment planning
• •Market consolidation anticipated as major animal health companies acquire specialized genetics platforms
• •Long-term projections suggest significant market expansion through 2030-2035 as genomic technologies become standard in veterinary care